Literature DB >> 3305367

Identification of two different hemolysin determinants in uropathogenic Proteus isolates.

R A Welch.   

Abstract

DNA sequences similar to those of the Escherichia coli hemolysin genes were detected among uropathogenic isolates of Proteus vulgaris and Morganella morganii by using the Southern blotting technique and hly gene-specific DNA probe. Immunoblotting revealed that among the hemolytic P. vulgaris and M. morganii isolates there was expressed a polypeptide species similar in molecular size (110 kilodaltons) and antigenicity to Escherichia coli HlyA. A plasmid-mediated P. vulgaris hemolysin determinant identified by Southern blotting analysis was molecularly cloned, and the recombinant plasmid (pWPV100) was characterized by restriction endonuclease fragment mapping. A second recombinant library of genomic DNA prepared from a hemolytic, urinary tract isolate of Proteus mirabilis was constructed in E. coli. A 5.5-kilobase XhoI fragment encoding an extracellular hemolytic activity was molecularly cloned (pWPM100), and this plasmid was subjected to transposon-mediated mutagenesis with TnphoA. The P. mirabilis hemolytic phenotype was determined to be encoded by a polypeptide species (HpmA) with an estimated molecular size of 140 kilodaltons based on minicell polypeptide analysis of pWPM100 and its mutant derivatives. Southern blotting analysis with a HpmA-specific DNA probe revealed that this novel determinant is commonly found in both Proteus species but is not present in hemolytic isolates of M. morganii, E. coli, Citrobacter freundii, and Serratia marcescens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3305367      PMCID: PMC260676          DOI: 10.1128/iai.55.9.2183-2190.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  Epidemiology of nosocomial infection due to Gram-negative bacilli: aspects relevant to development and use of vaccines.

Authors:  W E Stamm; S M Martin; J V Bennett
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

4.  Etiology of pyelonephritis: significance of hemolytic Escherichia coli.

Authors:  F A Fried; R J Wong
Journal:  J Urol       Date:  1970-06       Impact factor: 7.450

5.  Some factors affecting production and assay of Escherichia coli haemolysins.

Authors:  I S Snyder; P Zwadyk
Journal:  J Gen Microbiol       Date:  1969-01

6.  The significance of urease in proteus pyelonephritis: a histological and biochemical study.

Authors:  D M MacLaren
Journal:  J Pathol       Date:  1969-01       Impact factor: 7.996

7.  Role of urease in pyelonephritis resulting from urinary tract infection with Proteus.

Authors:  D M Musher; D P Griffith; D Yawn; R D Rossen
Journal:  J Infect Dis       Date:  1975-02       Impact factor: 5.226

Review 8.  Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients.

Authors:  B E Kreger; D E Craven; P C Carling; W R McCabe
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

9.  Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations.

Authors:  L S Young; W J Martin; R D Meyer; R J Weinstein; E T Anderson
Journal:  Ann Intern Med       Date:  1977-04       Impact factor: 25.391

10.  Hemolysin and K antigens in relation to serotype and hemagglutination type of Escherichia coli isolated from extraintestinal infections.

Authors:  D J Evans; D G Evans; C Höhne; M A Noble; E V Haldane; H Lior; L S Young
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

View more
  51 in total

Review 1.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

2.  Mutations affecting pore formation by haemolysin from Escherichia coli.

Authors:  A Ludwig; A Schmid; R Benz; W Goebel
Journal:  Mol Gen Genet       Date:  1991-04

3.  Cytotoxicity of the HpmA hemolysin and urease of Proteus mirabilis and Proteus vulgaris against cultured human renal proximal tubular epithelial cells.

Authors:  H L Mobley; G R Chippendale; K G Swihart; R A Welch
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

4.  Characterization of monoclonal antibodies against the Escherichia coli hemolysin.

Authors:  S Pellett; D F Boehm; I S Snyder; G Rowe; R A Welch
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

Review 5.  The different hemolysins of Escherichia coli.

Authors:  L Beutin
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

Review 6.  Acyltransferases in bacteria.

Authors:  Annika Röttig; Alexander Steinbüchel
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

7.  Nucleotide sequencing of the Proteus mirabilis calcium-independent hemolysin genes (hpmA and hpmB) reveals sequence similarity with the Serratia marcescens hemolysin genes (shlA and shlB).

Authors:  T S Uphoff; R A Welch
Journal:  J Bacteriol       Date:  1990-03       Impact factor: 3.490

8.  Cloning and characterization of hemolytic genes from Helicobacter pylori.

Authors:  E S Drazek; A Dubois; R K Holmes; D Kersulyte; N S Akopyants; D E Berg; R L Warren
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 9.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

10.  Cytotoxic activity of the Proteus hemolysin HpmA.

Authors:  K G Swihart; R A Welch
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.